These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 26820965)

  • 1. Imaging Matrix Metalloproteinase Activity Implicated in Breast Cancer Progression.
    Fields GB; Stawikowski MJ
    Methods Mol Biol; 2016; 1406():303-29. PubMed ID: 26820965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of H-aggregation on activatable MMP-2-specific probes for optical imaging.
    Lebel R; Bonin MA; Zriba R; Radulska A; Neugebauer W; Lepage M
    Contrast Media Mol Imaging; 2012; 7(3):328-37. PubMed ID: 22539403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assays of matrix metalloproteinases (MMPs) activities: a review.
    Lombard C; Saulnier J; Wallach J
    Biochimie; 2005; 87(3-4):265-72. PubMed ID: 15781313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple-helical peptide analysis of collagenolytic protease activity.
    Lauer-Fields JL; Fields GB
    Biol Chem; 2002; 383(7-8):1095-105. PubMed ID: 12437092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissecting MMP P
    Tokmina-Roszyk M; Fields GB
    J Biol Chem; 2018 Oct; 293(43):16661-16676. PubMed ID: 30185620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioactive smart probe for potential corrected matrix metalloproteinase imaging.
    Huang CW; Li Z; Conti PS
    Bioconjug Chem; 2012 Nov; 23(11):2159-67. PubMed ID: 23025637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase interactions with collagen and elastin.
    Van Doren SR
    Matrix Biol; 2015; 44-46():224-31. PubMed ID: 25599938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods for the Construction of Collagen-Based Triple-Helical Peptides Designed as Matrix Metalloproteinase Inhibitors.
    Fields GB
    Methods Mol Biol; 2019; 1944():229-252. PubMed ID: 30840247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collagenolytic Matrix Metalloproteinase Activities toward Peptomeric Triple-Helical Substrates.
    Stawikowski MJ; Stawikowska R; Fields GB
    Biochemistry; 2015 May; 54(19):3110-21. PubMed ID: 25897652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased precision of orthotopic and metastatic breast cancer surgery guided by matrix metalloproteinase-activatable near-infrared fluorescence probes.
    Chi C; Zhang Q; Mao Y; Kou D; Qiu J; Ye J; Wang J; Wang Z; Du Y; Tian J
    Sci Rep; 2015 Sep; 5():14197. PubMed ID: 26395067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of matrix metalloproteinases (MMPs) in breast cancer xenografts: a major induction of stromal MMP-13.
    Lafleur MA; Drew AF; de Sousa EL; Blick T; Bills M; Walker EC; Williams ED; Waltham M; Thompson EW
    Int J Cancer; 2005 Apr; 114(4):544-54. PubMed ID: 15551360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinase 26 proteolysis of the NH2-terminal domain of the estrogen receptor beta correlates with the survival of breast cancer patients.
    Savinov AY; Remacle AG; Golubkov VS; Krajewska M; Kennedy S; Duffy MJ; Rozanov DV; Krajewski S; Strongin AY
    Cancer Res; 2006 Mar; 66(5):2716-24. PubMed ID: 16510592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design strategy for a near-infrared fluorescence probe for matrix metalloproteinase utilizing highly cell permeable boron dipyrromethene.
    Myochin T; Hanaoka K; Komatsu T; Terai T; Nagano T
    J Am Chem Soc; 2012 Aug; 134(33):13730-7. PubMed ID: 22830429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability.
    Müller A; Krämer SD; Meletta R; Beck K; Selivanova SV; Rancic Z; Kaufmann PA; Vos B; Meding J; Stellfeld T; Heinrich TK; Bauser M; Hütter J; Dinkelborg LM; Schibli R; Ametamey SM
    Nucl Med Biol; 2014 Aug; 41(7):562-9. PubMed ID: 24853402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining the Substrate Specificity of Matrix Metalloproteases using Fluorogenic Peptide Substrates.
    Stawikowski MJ; Knapinska AM; Fields GB
    Methods Mol Biol; 2017; 1579():137-183. PubMed ID: 28299736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity.
    Merrell MA; Ilvesaro JM; Lehtonen N; Sorsa T; Gehrs B; Rosenthal E; Chen D; Shackley B; Harris KW; Selander KS
    Mol Cancer Res; 2006 Jul; 4(7):437-47. PubMed ID: 16849519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical biology for understanding matrix metalloproteinase function.
    Knapinska A; Fields GB
    Chembiochem; 2012 Sep; 13(14):2002-20. PubMed ID: 22933318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-invasive, antitumoral, and antiangiogenic efficacy of a pyrimidine-2,4,6-trione derivative, an orally active and selective matrix metalloproteinases inhibitor.
    Maquoi E; Sounni NE; Devy L; Olivier F; Frankenne F; Krell HW; Grams F; Foidart JM; Noël A
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4038-47. PubMed ID: 15217936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supramolecular gelatin nanoparticles as matrix metalloproteinase responsive cancer cell imaging probes.
    Xu JH; Gao FP; Liu XF; Zeng Q; Guo SS; Tang ZY; Zhao XZ; Wang H
    Chem Commun (Camb); 2013 May; 49(40):4462-4. PubMed ID: 23508115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular contractility and extracellular matrix stiffness regulate matrix metalloproteinase activity in pancreatic cancer cells.
    Haage A; Schneider IC
    FASEB J; 2014 Aug; 28(8):3589-99. PubMed ID: 24784579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.